Literature DB >> 18096875

HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells.

Jin-Tang Chen1, Chih-Yang Huang, Yung-Yen Chiang, Wen-Heng Chen, Shiow-Her Chiou, Chih-Yi Chen, Kuan-Chih Chow.   

Abstract

Our previous study had shown that advanced stages of lung adenocarcinomas (ADC) was frequently associated with overexpression of hepatocyte growth factor (HGF), which has multipotent and anti-apoptotic activities. In this study, we examined the effect of HGF on gene expression of apoptosis-inducing factor (AIF) and cisplatin sensitivity in lung ADC cells. Expression of AIF was determined by immunocytochemistry and confocal immunofluorescence microscopy. Our data show that addition of HGF suppressed AIF expression and increased cisplatin resistance. The effect could be through HGF receptor and its downstream effector, focal adhesion kinase (FAK). Interestingly, knockout of FAK gene increased AIF expression and drug sensitivity. Re-introduction of FAK gene, on the other hand, restored drug resistance. These results suggested that HGF might induce cisplatin resistance via c-Met to activate FAK and down-regulate AIF expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096875     DOI: 10.1165/rcmb.2007-0001OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  25 in total

1.  Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1'S-1'-acetoxychavicol acetate and cisplatin.

Authors:  Neoh Hun Phuah; Lionel L A In; Mohamad Nurul Azmi; Halijah Ibrahim; Khalijah Awang; Noor Hasima Nagoor
Journal:  Reprod Sci       Date:  2012-09-25       Impact factor: 3.060

Review 2.  Molecular determinants of lung cancer metastasis to the central nervous system.

Authors:  Timothy G Whitsett; Landon J Inge; Harshil D Dhruv; Philip Y Cheung; Glen J Weiss; Ross M Bremner; Jeffrey A Winkles; Nhan L Tran
Journal:  Transl Lung Cancer Res       Date:  2013-08

3.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

Review 4.  c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer.

Authors:  Daniel Delitto; Eva Vertes-George; Steven J Hughes; Kevin E Behrns; Jose G Trevino
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.

Authors:  Zhongcheng Zhu
Journal:  Oncol Lett       Date:  2018-04-05       Impact factor: 2.967

Review 6.  Apoptosis-inducing factor: structure, function, and redox regulation.

Authors:  Irina F Sevrioukova
Journal:  Antioxid Redox Signal       Date:  2011-03-10       Impact factor: 8.401

7.  Survivin monomer plays an essential role in apoptosis regulation.

Authors:  Marat S Pavlyukov; Nadezhda V Antipova; Maria V Balashova; Tatjana V Vinogradova; Evgenij P Kopantzev; Mihail I Shakhparonov
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

Review 8.  Role of HGF/MET axis in resistance of lung cancer to contemporary management.

Authors:  Kanwal Pratap Singh Raghav; Ana Maria Gonzalez-Angulo; George R Blumenschein
Journal:  Transl Lung Cancer Res       Date:  2012-09

9.  Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

Review 10.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.